Liver Stiffness Linked to Hepatic Events, Death in Hepatitis B

This article originally appeared here.
Share this content:
Liver Stiffness Linked to Hepatic Events, Death in Hepatitis B
Liver Stiffness Linked to Hepatic Events, Death in Hepatitis B

MONDAY, Oct. 17, 2016 (HealthDay News) -- For patients with chronic hepatitis B (CHB), liver stiffness measurement (LSM) is associated with hepatic events and death, while metabolic syndrome increases the risk of cardiovascular events, according to a study published online Oct. 1 in Hepatology.

Jenny Yeuk-Ki Cheng, from the Chinese University of Hong Kong, and colleagues recruited 1,466 CHB patients for LSM with transient elastography and detailed metabolic profiling. Patients were followed for any clinical event.

The researchers found that 93 and 44 patients developed hepatic and cardiovascular events, respectively, at a mean follow-up of 88 ± 20 months; 70 patients died. The cumulative probability of hepatic events was higher for patients with baseline LSM >8.0 kPa versus ≤8.0 kPa at eight years (12.3 versus 3.1 percent; P < 0.001). The cumulative probability of cardiovascular events was higher for patients with metabolic syndrome (8.0 versus 2.1 percent; P < 0.001). High LSM had no impact on cardiovascular events, and metabolic syndrome had no effect on hepatic events. LSM >8.0 kPa was an independent risk factor for death (adjusted hazard ratio, 1.9; 95 percent confidence interval, 1.1 to 3.2); metabolic syndrome was not (adjusted hazard ratio, 1.3; 95 percent confidence interval, 0.8 to 2.4).

"Metabolic syndrome increased the risk of cardiovascular events but not hepatic events and death; LSM was the important risk factor of hepatic events and death in CHB patients," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »